Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News bluebird bio Inc BLUE

Healthcare Biotechnology
bluebird bio, Inc. is a biotechnology company. The Company is focused on researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its lentiviral vector (LVV) gene addition platform. Its lead gene therapy programs for sickle cell disease, B-thalassemia, and cerebral adrenoleukodystrophy and is advancing research to apply new... see more

Recent & Breaking News (NDAQ:BLUE)

bluebird bio Appoints Chip Baird as Chief Financial Officer

Business Wire February 11, 2019

ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Motorcar Parts of America, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

GlobeNewswire January 21, 2019

bluebird bio and Inhibrx Announce Collaboration to Research, Develop and Commercialize CAR T Cell Immunotherapies

Business Wire January 7, 2019

ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against AxoGen, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

GlobeNewswire January 3, 2019

bluebird bio to Present at the 37th Annual J.P. Morgan Healthcare Conference

Business Wire January 3, 2019

Lifshitz & Miller LLP Announces Investigation of Bluebird Bio, Inc., Cavco Industries, Inc., Edge Therapeutics, Inc., Inuvo, Inc., Lumentum Holdings, Inc., National Commerce Corporation, and Nobilis Health Corp.

PR Newswire December 28, 2018

ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Yangtze River Port and Logistics Limited and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

GlobeNewswire December 27, 2018

INVESTIGATION ALERT REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Yangtze River Port and Logistics Limited and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Business Wire December 26, 2018

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Yangtze River Port and Logistics Limited and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Business Wire December 24, 2018

EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against AxoGen, Inc. – AXGN

Business Wire December 24, 2018

The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial

Benzinga.com  December 21, 2018

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Bluebird Bio, Inc. Investors (BLUE)

Business Wire December 18, 2018

Glancy Prongay & Murray LLP Announces Investigation on Behalf of Bluebird Bio, Inc. Investors (BLUE)

Business Wire December 17, 2018

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of bluebird bio, Inc.

GlobeNewswire December 14, 2018

Glancy Prongay & Murray LLP Announces Investigation on Behalf of Bluebird Bio, Inc. Investors (BLUE)

Business Wire December 13, 2018

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of CURO Group Holdings Corp. Investors (CURO)

Business Wire December 12, 2018

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Huazhu Group Limited - HTHT

GlobeNewswire December 7, 2018

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of bluebird bio, Inc. - BLUE

PR Newswire December 5, 2018

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of bluebird bio, Inc. (BLUE)

GlobeNewswire December 5, 2018

The Daily Biotech Pulse: ASH Presentations Take The Spotlight, Eiger Gets A New CFO

Benzinga.com  December 4, 2018